Bionano genomics news
Nov 3, 2022 at 4:30 PM EDT. Sep 12, 2022 at 7:00 AM EDT. 2022 Maxim Virtual Growth Conference. Mar 15, 2022 at 8:40 AM EDT. Please click HERE to join. Mar 9, 2022 at 2:10 PM EST. 42nd Annual Cowen Healthcare Conference. Please click HERE to join. Mar 1, 2022 at 4:30 PM EST.Aug 7, 2023 · Bionano Genomics (NASDAQ: BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ...
Did you know?
Q2 2023 revenue was $8.7 million , which represents a 30% increase over Q2 2022 Installed base of Saphyr ® systems totaled 281 as of June 30, 2023 , which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023 , which represents a 108% increase over theSAN DIEGO, April 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American Association for Cancer Research (AACR) Annual Meeting 2023 ...About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting. Oct '23. Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan. Oct '23.Visualize multiple tracks of genomic data for the at-a-glance context of variant calls. NₓClinical offers multi-platform integration by: Combining current and historical molecular data from array and sequencing for sample continuity. Comparing and contrasting outputs from multiple technologies to understand the underlying biology.Submissions focused on a variety of applications including genetic disease, cancer, reproductive health, cell and gene therapy, and plant and animal research. SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr ...About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.13 Jun 2023 ... News Release Details. « Back. Bionano Announces Presentation of OGM ... © 2023 Bionano Genomics, Inc. All rights reserved. For Research Use ...View the latest Bionano Genomics Inc. (BNGO) stock price, news, historical charts, analyst ratings and financial information from WSJ.Latest BioNano Genomics Inc Stock News. As of November 24, 2023, BioNano Genomics Inc had a $56.3 million market capitalization, putting it in the 30th percentile of companies in the Advanced Medical Equipment & Technology industry. BioNano Genomics Inc does not have a meaningful P/E due to negative earnings over …Sep 30, 2022 · Nov. 08, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended Business Updates Since the End of Q3 2023 Q3 2023 Highlights 6,176 nanochannel array flowcells sold during the third quarter Initiated early access program for Stratys™ system , which are ongoing, $1,863.22 Bionano’s Stratys system for OGM offers increased throughput capabilities to address the needs of mid and high-volume ... Bionano Genomics, Inc. +1 (858) 888-7610 [email protected]. Investor ...Jul 6, 2021 · About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business ... SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from researchers at Radboud University Medical Center showing the use of optical genome mapping (OGM) to identify gene disruptive structural variants (SVs) that might contribute to inherited retinal diseases …Aug 28, 2023 · A-smart is Bionano’s second Chinese OEM partner to obtain approval from NMPA for the Company’s optical genome mapping (OGM) solutions. NMPA issued two approvals to A-smart: one for Bionano’s G2 direct label and stain (DLS) DNA labeling kit and one for Bionano’s G2 SP bone marrow aspirate (BMA) DNA isolation kit. SAN DIEGEO, May 05, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of NxClinical™ software, a leading solution for visualization, interpretation and reporting of genomic data, today reported financial results for the first quarter ended ...Q2 2023 revenue was $8.7 million , which represents a 30% increase over Q2 2022 Installed base of Saphyr ® systems totaled 281 as of June 30, 2023 , which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023 , which represents a 108% increase over theUPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates. Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022. Installed base of Saphyr® systems reached 259 as of March 31, 2023, which represents growth of the …Jun 13, 2023 · SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem ... Get the latest BioNano Genomics Inc (BNGO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 12 Okt 2021 ... Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics ...Bionano also sold 3,204 nanochannel array flow cells during the quarter, representing 29 percent growth over the same quarter of 2020. Increased sales of flow cells "indicate more utilization in the field, which in turn leads to more data, more publications, more presentations, and, we believe, more demand for optical genome mapping," …After surging to an all-time high early in 2021, Bionano Genomics ... By Shrey Dua, InvestorPlace Assistant News Writer Dec 1, 2023 ADVERTISEMENT. Most Popular Today's Market ...
Positive. Nikkei 225. 33,431.51. -0.17%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Bionano Genomics Inc (BNGO.OQ) real-time stock quotes, news, price and financial ...Oct 26, 2023 · For the last reported quarter, it was expected that Bionano Genomics, Inc. Would post a loss of $0.90 per share when it actually produced a loss of $1.24, delivering a surprise of -37.78%. According to data from Benzinga Pro, BioNano Genomics is trading lower by 1.6% to $1.23. BNGO has a 52-week high of $4.35 and a 52-week low of $1.16. Photo via Shutterstock.GuruFocus Research November 8, 2023 at 6:19 PM · 4 min read Bionano Genomics Inc ( NASDAQ:BNGO) sees a 29% increase in Q3 2023 revenue, reaching …
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr ® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the release of Bionano Solve™ version 3.7 and Bionano Access™ version 1.7 as available data solution …Sep 23, 2022 · SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT). …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Aug 9, 2023 · Nov 3, 2022 at 4:30 PM EDT. Sep 12, 2022 at 7:00 AM ED. Possible cause: News Release Details « Back. Bionano Reports Second Quarter 2023 Results and High.
Jan 12, 2023 · About Bionano Genomics, Inc. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. 4 Agu 2023 ... Bionano Genomics, Inc. (BNGO) will effect a one-for-ten (1-10) ... Nasdaq offers customers the ability to self select news delivery across various ...14 Okt 2021 ... 22, 2021. Source: Bionano Genomics. Related Content: Bio/Pharma News ...
Based on BioNano Genomics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $7.22 million and a GAAP net loss of $31.81 million.Dec 4, 2023 · Over the past 30 days, the shares of Bionano Genomics Inc (NASDAQ:BNGO) have changed 24.81%. Short interest in the company has seen 7.08 million shares shorted with days to cover at 6.06. Wall Street analysts have a consensus price target for the stock at $12.33, which means that the shares’ value could jump 86.54% from current levels. Jan 12, 2023 · About Bionano Genomics, Inc. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.
Bionano Genomics currently dominates the optical mapping mark SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. (Purigen), a company that develops and commercializes automated nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP ...Based on BioNano Genomics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $7.22 million and a GAAP net loss of $31.81 million. SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- BiSAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago. Jun 12, 2023 · Submissions focused on a variety of applicat SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification ...Get the latest Bionano Genomics, Inc. (BNGO) stock news and headlines to help you in your trading and investing decisions. Bionano Genomics (NASDAQ:BNGO) effected a 1Bionano Genomics: PB2245: A combination of exoSAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bio About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing ... NEW YORK – Bionano Genomics this week executed a new roun Bionano Genomics (BNGO 4.40%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ... 12 Okt 2021 ... Bionano Genomics is acquiring genomics software firm [Bionano Genomics is a provider of genome anaView BioNano Genomics (www.bionanogenomics.com) loca SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today.The final voting results will be available in a current report on Form 8-K, which will be filed with the SEC within 4 days of the meeting. “We appreciate …The market expects Bionano Genomics, Inc. (BNGO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2022.